Karel J. van Erpecum

Author

Also Known As

H.R. van Buuren, K J VAN ERPECUM, K J Van Erpecum, K J van Erpecum, K. J. VAN ERPECUM, K. J. Van ERPECUM, K. J. Van Erpecum, K. J. van Erpecum, K.J van Erpecum, K.J. Van Erpecum

345

Publications

14K

Citations

H-Index

107

Concepts

All Affiliations

University Medical Center Utrecht Utrecht University Amsterdam UMC Location University of Amsterdam Erasmus MC Radboud University Nijmegen

About

Karel J. van Erpecum is an author at University Medical Center Utrecht specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	46	3K
2	Health Sciences	9	9	294
3	Public Health	4	4	277
4	Natural Sciences	3	3	94
5	Engineering	1	1	72

Karel J. van Erpecum

128

Publications

10.5K

Citations

H-Index

Page 1

	Year	Citations
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis Frederik Nevens, Pietro Andreoné, G. Mazzella, New England Journal of Medicine	2016	1.1K
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease Raffaella Maria Gadaleta, Karel J. van Erpecum, Bas Oldenburg, Gut	2011	827
Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis Kirsten Boonstra, Rinse K. Weersma, Karel J. van Erpecum, Hepatology	2013	689
Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid Edith M.M. Kuiper, Bettina E. Hansen, Richard A. de Vries, Gastroenterology UrologyHepatologyBiliary TractLiver PhysiologyGastroenterology	2009	451
Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus Andreas E. Kremer, Job J.W.W. Martens, Wim Kulik, Gastroenterology Animal PhysiologyOxysterolMedicinePhysiologyLysophosphatidic Acid	2010	399
Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1 Ynto S. de Boer, Nicole M. F. van Gerven, Antonie Zwiers, Gastroenterology Genome-wide Association StudyAutoimmune DiseaseGenotype-phenotype AssociationGeneticsGenetic Epidemiology	2014	298
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions Andreas E. Kremer, Remco van Dijk, Pamela Leckie, Hepatology	2012	283
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease Kirsten Boonstra, Karel J. van Erpecum, Karin M.J. van Nieuwkerk, Inflammatory Bowel Diseases	2012	250
Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission Nicole M. F. van Gerven, Bart J. Verwer, Birgit I. Lissenberg‐Witte, Journal of Hepatology HepatologyAutoimmune DiseaseImmunosuppressive TherapyImmunologyHepatitis	2012	225
Protein energy malnutrition predicts complications in liver cirrhosis Ellen J. Huisman, Evelien J. Trip, Peter D. Siersema, European Journal of Gastroenterology & Hepatology	2011	214

Page 1